Madison Square Garden Sports (MSGS) is preparing to split into two independent, publicly traded companies in late October. This corporate reshuffle can change how investors think about ownership and valuation of its sports franchises.
Recent trading has been choppy but upward leaning, with a 7 day share price return of 4.34% and a 30 day gain of 6.29%, while the 1 day move slipped 0.60% to US$413.84 as investors absorb the planned split and recent executive changes. Over a longer horizon, momentum has been strong, with a year to date share price return of 59.87% and a 1 year total shareholder return of 82.31%. This builds on a 3 year total shareholder return of 138.18% that keeps Madison Square Garden Sports in focus as the break up approaches.
Scan how other sports and entertainment owners are trading during this break up moment by comparing Madison Square Garden Sports against 17 high quality undiscovered gems that are poised around similar themes.
Madison Square Garden Sports now trades about 16% below the average analyst target after a sharp run and a looming split. Is that a sensible safety buffer, or a sign the market is too cautious on these franchises?
Most Popular Narrative: 14% Undervalued
Against the last close at $413.84, the most followed valuation narrative for Madison Square Garden Sports puts fair value at about $480.67, which implies a meaningful gap that investors are now weighing in light of the looming franchise split and mixed earnings outlook.
The upcoming ramp-up in high-value national media rights fees for the NBA (beginning in fiscal '26) will offset the recent step-down in local media rights, positioning MSG Sports for an overall increase in recurring media revenue and supporting both revenue growth and higher net margins over the next several years.
Expanded international partnerships and marketing deals, such as with Abu Dhabi's Department of Culture and Tourism, signal rising global interest in the Knicks and Rangers franchises, enhancing sponsorship income and merchandise opportunities, which are likely to boost top-line revenue.
See why 6 investors see Madison Square Garden Sports as 14% undervalued .
Result: Fair Value of $480.67 (UNDERVALUED)
Still, the narrative around Madison Square Garden Sports can be knocked off course if local media revenue weakens further or player and tax costs squeeze already thin margins.
Find out about the key risks to this Madison Square Garden Sports narrative .
Another View on Madison Square Garden Sports Valuation
The analyst narrative presents Madison Square Garden Sports as about 14% undervalued based on a fair value estimate of $480.67. A simple P/S check, however, suggests a different perspective. MSGS trades at 8.6x sales, compared with 1.2x for the US Entertainment group and a fair ratio of 1.1x, which indicates that a significant amount of optimism may already be reflected in the price. If the market moves closer to that fair ratio, how comfortable are you with the downside risk that such a shift could create?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
That mix of optimism and concern around Madison Square Garden Sports is exactly what creates debate. Move quickly, test the assumptions against your own thesis, and weigh the 1 key reward and 3 important warning signs .
Looking for more investment ideas beyond Madison Square Garden Sports?
If the MSGS story has sharpened your thinking, do not stop here. Cast a wider net now so you are not chasing the next opportunity after it has already moved.
-
Target resilient upside by reviewing 32 high quality undervalued stocks that combine strong fundamentals with pricing that still looks reasonable on key metrics.
-
Strengthen your income stream by scanning 6 dividend fortresses that focus on higher yields backed by more durable payout profiles.
-
Protect your downside by assessing 32 resilient stocks with low risk scores that score well on balance sheet quality and risk controls.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MSGS .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
